Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 14th, there was short interest totaling 15,534 shares, an increase of 103.9% from the July 30th total of 7,620 shares. Based on an average trading volume of 6,569 shares, the days-to-cover ratio is currently 2.4 days. Currently, 1.5% of the shares of the stock are sold short.
Global X HealthTech ETF Stock Down 1.0%
NASDAQ HEAL traded down $0.30 on Friday, reaching $29.72. The company had a trading volume of 2,484 shares, compared to its average volume of 10,897. The stock has a market capitalization of $31.50 million, a PE ratio of 42.80 and a beta of 1.10. The firm’s 50 day moving average price is $28.22 and its 200 day moving average price is $26.30. Global X HealthTech ETF has a 12 month low of $23.00 and a 12 month high of $33.59.
Institutional Investors Weigh In On Global X HealthTech ETF
Several large investors have recently made changes to their positions in HEAL. Glenmede Investment Management LP bought a new position in Global X HealthTech ETF during the third quarter valued at approximately $31,000. Banque Cantonale Vaudoise bought a new stake in Global X HealthTech ETF in the 3rd quarter worth approximately $37,000. EverSource Wealth Advisors LLC raised its holdings in shares of Global X HealthTech ETF by 26,522.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock worth $70,000 after acquiring an additional 2,387 shares in the last quarter. Royal Bank of Canada raised its holdings in shares of Global X HealthTech ETF by 39.4% during the 1st quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after acquiring an additional 736 shares in the last quarter. Finally, Farther Finance Advisors LLC bought a new position in shares of Global X HealthTech ETF during the 4th quarter valued at approximately $111,000.
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
See Also
- Five stocks we like better than Global X HealthTech ETF
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
